Cancer Center to Use Wellness Professionals(TM) Ximega(TM) Omega-3 Supplement in Clinical Trial to Study Efficacy in Patients With Depression and Pancreatic Cancer
Posted on: Monday, 28 July 2008, 06:01 CDT
Numerous studies have shown the benefits of omega-3 fatty acids for everything from decreasing joint pain to improving cardiovascular and ophthalmologic health. Depression is another condition garnering attention from researchers studying the benefits of omega-3s. Wellness Professionals(TM), the leader in arthritis pain relief, is pleased to announce that their omega-3 supplement, Ximega(TM), will be used in a clinical trial at Memorial Sloan Kettering Cancer Center as a treatment for depression.
The trial will study a difficult-to-treat patient population suffering from major depressive disorder and pancreatic cancer. At the conclusion of the trial, which will run through 2009, researchers will know if Ximega(TM) omega-3 supplements are a viable solution for patients who may not respond to anti-depressants alone, or who may prefer a non-pharmaceutical approach to treating depression.
Numerous clinical studies have shown evidence that omega-3s are valuable in treating a variety of common conditions. Omega-3s have been shown to help with high cholesterol, high blood pressure, heart disease, diabetes, arthritis pain relief, osteoporosis, depression, skin disorders, macular degeneration, and some cancers. Additional research is under way to test the efficacy of omega-3s in treating autism, migraines, lupus, and multiple sclerosis.
Omega-3 fatty acids have also been linked to cognitive and behavioral function and it is especially important for women during pregnancy to have enough omega-3 fatty acids. Babies whose mothers lack omega-3 are at risk for developing vision and neurological problems.
"I increasingly recommend Omega-3 to my patients and Wellness Professionals(TM) is a great partner with the best quality product," says Kristen Kratzert, MD, of Syracuse, New York.
The difference between Ximega(TM) and the omega-3s you can buy at a drugstore or supermarket is that Ximega(TM) is manufactured in an FDA registered facility that also makes prescription pharmaceuticals. As a result, all equipment, labeling, manufacturing processes and standards are FDA inspected and certified.
Ximega(TM) is a softgel supplement containing 952mg of two omega-3 acid ethyl esters, EPA and DHA. These omega-3s are integral to good health and cannot be produced in the body. In addition, the ethyl ester form of EPA and DHA is absorbed by the human body much more easily than the triglyceride form, more commonly found in supplements. Ximega(TM) is molecularly distilled to remove impurities and contains no organomercurial materials.
For additional information on the Ximega(TM) omega-3 supplement, the clinical trial, or other supplements for joint pain relief, contact Matt Hall or visit http://www.wellnessprofessionals.com.
About Wellness Professionals(TM):
Our mission is to help people prevent, solve, and relieve musculoskeletal pain. We offer an integrated set of resources (health information, diagrams & pictures, lifestyle tips, products, supplements, exercises, and online community) targeted to 100 common musculoskeletal conditions.
Contact: Matt Hall CEO Wellness Professionals (617) 649-2119 http://www.wellnessprofessionals.com
SOURCE: Wellness Professionals
Source: MARKET WIRE
Related Articles
- Affymax Completes Enrollment in PEARL 2, the Second of Four Phase 3 Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients
- Gentium Announces the Data Safety Monitoring Board Review of the Phase III Trial of Defibrotide to Treat Patients With Severe Veno-Occlusive Disease
- MyNutritionStore.Com Launches Virtual Reality Nutrition Store to Boost Income for Trainers and Wellness Professionals
- AVANIR Announces Last Patient Enrolled in Neuropathic Pain Phase III Trial With Zenvia
- Omega-3 Fatty Acids May Help Kids with Depression
- Mother-Child Depression Linked ; Treating Parents Can Safeguard Offspring, Study Finds
- Assessment of Canadian Provincial Expenditures in Depressed Patients Treated With Venlafaxine XR Versus SSRIs: the APEX Study
- New Gout Drug Does Well in Trial
- Anti-Obesity Pill Does Well in Trial
User Comments (0)

RSS Feeds